Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
NCT ID: NCT00971880
Last Updated: 2011-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2009-05-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to summarize the data of those complications in a cohort of 100 patients receiving regular blood transfusion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Pain in People With Thalassemia
NCT00872339
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
NCT00872833
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221
Invasive Infections in Children With Hemoglobinopathies
NCT00456443
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A second goal of this study will be to control the staff strictness related to the ministry of health protocol dealing to blood transfusions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients receiving blood transfusions
All the patients with blood disorders that require blood transfusions
Clinical medical record summary
Summary of immediate and late adverse effects of blood transfusions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical medical record summary
Summary of immediate and late adverse effects of blood transfusions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Koren Ariel
Head of Pediatric Hematology Unit and Pediatric Dpt B
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0039-09-EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.